Separation of thorium-229 for production of alpha emitters
Journal Article
·
· Transactions of the American Nuclear Society
OSTI ID:552716
- Oak Ridge National Lab., TN (United States); and others
The purpose of this program is to produce isotopes from the neptunium decay series for medical research and potential clinical applications. Members of the neptunium series may be well suited for medical applications because of their relatively high energy emissions from alpha decays. We describe the separation of {sup 229}Th from two different sources. In the first case, thorium ({sup 229}Th mixed with natural thorium) was the most abundant species of a residual from prior {sup 233}U processing. In the second case, milligram quantities of {sup 229}Th are separated from kilogram quantities of uranium. We describe the performance of Reillex HPQ anion-exchange resin for separating thorium in these two situations.
- OSTI ID:
- 552716
- Report Number(s):
- CONF-971125--
- Journal Information:
- Transactions of the American Nuclear Society, Journal Name: Transactions of the American Nuclear Society Vol. 77; ISSN 0003-018X; ISSN TANSAO
- Country of Publication:
- United States
- Language:
- English
Similar Records
Purification of thorium from uranium-233 process residue
ORNL production of the experimental alpha emitters bismuth-213 and actinium-225 for medical applications
FINE STRUCTURE OF Th$sup 229$ $alpha$ SPECTRUM
Journal Article
·
Wed Mar 31 23:00:00 EST 1999
· Separation Science and Technology
·
OSTI ID:354462
ORNL production of the experimental alpha emitters bismuth-213 and actinium-225 for medical applications
Journal Article
·
Tue Sep 01 00:00:00 EDT 1998
· Transactions of the American Nuclear Society
·
OSTI ID:644233
FINE STRUCTURE OF Th$sup 229$ $alpha$ SPECTRUM
Journal Article
·
Wed Jul 01 00:00:00 EDT 1959
· Izvest. Akad. Nauk. S.S.S.R., Ser. Fiz.
·
OSTI ID:4225635